Steven Hoffman, Director of the Global Strategy Lab, recently contributed to a Nature news feature where he highlighted the importance of establishing a global unifying target for collective action against antimicrobial resistance (AMR). Drawing parallels with efforts to combat climate change, Hoffman advocated for the implementation of a global treaty to address this pressing issue. He underscored the urgency for stronger action, proposing a 35% reduction in drug-resistant infections by 2035 as a feasible goal for countries to unite behind. He also stressed the need for financial support from wealthier nations to aid those disproportionately affected by antibiotic resistance, mirroring efforts in climate-change politics.
Previous